I'd be shocked to see an offtake already... without a PFS on the table. I personally don't mind a CR - if it assures an outcome. If Paul comes to the table with a CR for PFS, I'll happily support it.
The outcome of the study will surely be worth the dilution, and then some.
AKO General Discussion, page-194
-
- There are more pages in this discussion • 560 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AKO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
-0.005(3.85%) |
Mkt cap ! $15.06M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 12.5¢ | 12.5¢ | $936 | 7.491K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18607 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 40004 | 1 |
View Market Depth
| Last trade - 15.07pm 08/11/2024 (20 minute delay) ? |
| AKO (ASX) Chart |